201 related articles for article (PubMed ID: 37105767)
1. The clinical effect of probiotics on patients with non-alcoholic fatty liver disease: a meta-analysis.
Wang Y; Wang Y; Sun J
Bioengineered; 2022; 13(7-12):14960-14973. PubMed ID: 37105767
[TBL] [Abstract][Full Text] [Related]
2. Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.
Ma YY; Li L; Yu CH; Shen Z; Chen LH; Li YM
World J Gastroenterol; 2013 Oct; 19(40):6911-8. PubMed ID: 24187469
[TBL] [Abstract][Full Text] [Related]
3. The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease - a systematic review and meta-analysis.
Khan MY; Mihali AB; Rawala MS; Aslam A; Siddiqui WJ
Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):703-715. PubMed ID: 31009401
[TBL] [Abstract][Full Text] [Related]
4. Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Loman BR; Hernández-Saavedra D; An R; Rector RS
Nutr Rev; 2018 Nov; 76(11):822-839. PubMed ID: 30113661
[TBL] [Abstract][Full Text] [Related]
5. Effect of Probiotics Therapy on Nonalcoholic Fatty Liver Disease.
Huang Y; Wang X; Zhang L; Zheng K; Xiong J; Li J; Cong C; Gong Z; Mao J
Comput Math Methods Med; 2022; 2022():7888076. PubMed ID: 35677177
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Probiotics and Synbiotics in Patients with Nonalcoholic Fatty Liver Disease: A Meta-Analysis.
Liu L; Li P; Liu Y; Zhang Y
Dig Dis Sci; 2019 Dec; 64(12):3402-3412. PubMed ID: 31203554
[TBL] [Abstract][Full Text] [Related]
7. Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Yang R; Shang J; Zhou Y; Liu W; Tian Y; Shang H
Expert Rev Gastroenterol Hepatol; 2021 Dec; 15(12):1401-1409. PubMed ID: 34877910
[TBL] [Abstract][Full Text] [Related]
8. Functional foods and dietary supplements in the management of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Wang LL; Zhang PH; Yan HH
Front Nutr; 2023; 10():1014010. PubMed ID: 36866059
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of exercise training processes in improving nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Yu X; Wang Y; Lai J; Song T; Duan J
Ir J Med Sci; 2023 Feb; 192(1):131-142. PubMed ID: 35366201
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of probiotics on nonalcoholic fatty liver disease: A meta-analysis.
Zhou X; Wang J; Zhou S; Liao J; Ye Z; Mao L
Medicine (Baltimore); 2023 Jan; 102(4):e32734. PubMed ID: 36705359
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy of probiotics in the treatment of alcoholic liver disease: a systematic review and meta-analysis.
Xiong SY; Wu GS; Li C; Ma W; Luo HR
Front Cell Infect Microbiol; 2024; 14():1358063. PubMed ID: 38533380
[TBL] [Abstract][Full Text] [Related]
12. Statin liver safety in non-alcoholic fatty liver disease: A systematic review and metanalysis.
Pastori D; Pani A; Di Rocco A; Menichelli D; Gazzaniga G; Farcomeni A; D'Erasmo L; Angelico F; Del Ben M; Baratta F
Br J Clin Pharmacol; 2022 Feb; 88(2):441-451. PubMed ID: 34133035
[TBL] [Abstract][Full Text] [Related]
13. Effect of metformin on nonalcoholic fatty liver based on meta-analysis and network pharmacology.
Huang Y; Wang X; Yan C; Li C; Zhang L; Zhang L; Liang E; Liu T; Mao J
Medicine (Baltimore); 2022 Oct; 101(43):e31437. PubMed ID: 36316840
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Yang K; Chen J; Zhang T; Yuan X; Ge A; Wang S; Xu H; Zeng L; Ge J
Front Immunol; 2022; 13():949746. PubMed ID: 36159792
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Metformin on Aminotransferase Levels, Metabolic Parameters and Body Mass Index in Nonalcoholic Fatty Liver Disease Patients: A Metaanalysis.
Hu H; Wang J; Li X; Shen L; Shi D; Meng J
Curr Pharm Des; 2021; 27(29):3235-3243. PubMed ID: 33719959
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of probiotics on the treatment of non-alcoholic fatty liver disease].
Wang W; Shi LP; Shi L; Xu L
Zhonghua Nei Ke Za Zhi; 2018 Feb; 57(2):101-106. PubMed ID: 29397594
[No Abstract] [Full Text] [Related]
17. A Multi-strain Probiotic Reduces the Fatty Liver Index, Cytokines and Aminotransferase levels in NAFLD Patients: Evidence from a Randomized Clinical Trial.
Kobyliak N; Abenavoli L; Mykhalchyshyn G; Kononenko L; Boccuto L; Kyriienko D; Dynnyk O
J Gastrointestin Liver Dis; 2018 Mar; 27(1):41-49. PubMed ID: 29557414
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of probiotics in patients with non-alcoholic fatty liver disease.
Cai GS; Su H; Zhang J
Medicine (Baltimore); 2020 Aug; 99(32):e21464. PubMed ID: 32769877
[TBL] [Abstract][Full Text] [Related]
19. The impact of gut microbiome-targeted therapy on liver enzymes in patients with nonalcoholic fatty liver disease: an umbrella meta-analysis.
Amini-Salehi E; Hassanipour S; Keivanlou MH; Shahdkar M; Orang Goorabzarmakhi M; Vakilpour A; Joukar F; Hashemi M; Sattari N; Javid M; Mansour-Ghanaei F
Nutr Rev; 2024 May; 82(6):815-830. PubMed ID: 37550264
[TBL] [Abstract][Full Text] [Related]
20. Systematic Review with Meta-Analysis: The Effects of Probiotics in Nonalcoholic Fatty Liver Disease.
Xiao MW; Lin SX; Shen ZH; Luo WW; Wang XY
Gastroenterol Res Pract; 2019; 2019():1484598. PubMed ID: 31885541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
